<DOC>
	<DOCNO>NCT02821377</DOCNO>
	<brief_summary>Introduction : Patients chronic liver disease usually thin result hypermetabolism malnutrition express reduced level leptin impairment adyponectins visfatin . Aims : To evaluate metabolic inflammatory effect intravenous high-dose furosemide plus hypertonic saline solution ( HSS ) compare repeat paracentesis standard oral diuretic schedule , patient cirrhosis refractory ascites . Methods ; All consecutive cirrhotic patient refractory ascites unresponsive outpatient treatment enrol . Enrolled subject randomize treatment intravenous infusion furosemide ( 125-250mg⁄bid ) plus small volume HSS first day admission 3 day discharge ( Group A ) , repeat paracentesis first day admission 3 day discharge ( Group B , ) . Plasma level ANP , BNP , Leptin , visfatin , IL-1β , TNF-a , IL-6 measure two type treatment .</brief_summary>
	<brief_title>Metabolic Effects Furosemide +HSS Refractory Ascites</brief_title>
	<detailed_description>Cirrhosis congestive heart failure ( CHF ) major clinical disease state characterize renal sodium water retention edema formation . Abnormalities circulatory volume homeostasis diseases elicit neuro-hormonal response influence renal function lead retention sodium water.Cytokines constitute complex network molecule involve regulation inflammatory response homeostasis organ function . Moreover cytokines coordinate physiologic pathologic process liver , liver growth regeneration , well inflammatory process include viral liver disease , liver fibrosis cirrhosis . Furthermore , patient chronic liver disease usually thin result hypermetabolism , diminish food intake , malnutrition , leptin think involved process . Furthermore , adipocytokines play important role lipid metabolism liver disease progression . Visfatin 52-kDa protein clone pre-B cell colony-enhancing factor ( PBEF ) , liver muscle report tissue high expression level protein . Recently , visfatin also propose adipokine secrete adipose tissue . A recent study report patient chronic HBV infection significantly high serum level adiponectin visfatin , low leptin level healthy control , serum adipocytokine level independently correlate HBV viremia , HBsAg level , liver fibrosis stage . Another recent study report subject alcoholic cirrhosis follow adjustment fat mass , visfatin level significantly high Child-Pugh Class A Class C. Furthermore , leptin , first describe adipokine , interplays hepatic metabolism , data small study suggest recombinant leptin administration possibly beneficial effect steatosis , fibrosis , NAFLD patient hypo-leptinemia recent study report non-alcoholic steatohepatitis ( NASH ) , leptin upregulated , promote liver fibrosis directly activate hepatic stellate cell ( HSC ) via hedgehog pathway hedgehog-regulated osteopontin ( OPN ) . Nevertheless , best knowledge , study address effectiveness treatment complication cirrhosis ascites fluid overload inflammatory metabolic abnormality . According International Ascites Club , refractory ascites define lack response high dos diuretic ( spironolactone 400mg⁄day furosemide 160mg⁄day ) development adverse effect ( hyperkalemia , hyponatremia , hepatic encephalopathy renal failure ) prohibit use diuretic . A recent clinical trial report intravenous hypertonic saline solution ( HSS ) plus high-dose furosemide safe effective alternative repeat paracentesis treat hospitalized patient cirrhosis refractory ascites . Specific objective hypothesis : On basis , hypothesis trial clinical effectiveness high dose furosemide + HSS could accomplish parallel effect inflammatory , natriuretic metabolic pathway express change cytokine , natriuretic peptide , leptin visfatin serum level treatment . Thus aim trial evalute metabolic inflammatory effect intravenous high-dose furosemide plus HSS compare repeat paracentesis standard oral diuretic schedule , patient cirrhosis refractory ascites , evaluate effect panel serum biomarkers inflammatory cytokine , ANP/BNP , leptin visfatin serum level mean analysis difference serum level treatment high dose furosemide + HSS . Materials methods All consecutive cirrhotic patient present ascites unresponsive ambulatory treatment Palermo University Hospital ( Azienda Ospedaliera Policlinico 'Paolo Giaccone ' ) admit Internal Medicine Ward December 2013 December 2015 offer enrolment study protocol diagnosis ascites make potential contraindication exclude . Refractory ascites define accord International Ascites Club criteria 1 either : ( ) diuretic-resistant refractory ascites : &lt; 1.5kg ⁄week weight loss treat furosemide ( 160mg⁄day ) spironolactone ( 400mg⁄day ) equivalent dose loop-acting distal-acting diuretic ; ( b ) diuretic-intractable refractory ascites : &lt; 1.5kg⁄week weight loss result inability use effective dose diuretic development diuretic-induced hyponatremia ( sodium level &lt; 125mEq⁄ L ) , hyperkalemia ( potassium level &gt; 5.5mEq⁄L ) , renal failure ( double serum creatinine value &gt; 2.5g⁄dL ) encephalopathy ; ( c ) previous dietary restriction sodium 50-66mEq ⁄day . Exclusion criterion : inability obtain informed consent , possible non-cirrhotic ascites , congestive heart failure ( defined clinical exam echocardiogram ) , acute renal failure , hepatocellular carcinoma base Barcelona Clinic liver Cancer ( BCLC ) criterion , complete portal vein thrombosis , active sepsis incurable cancer . The study approve institutional Ethics Committee write informed consent obtain patient . Daily clinical laboratory evaluation Treatment protocol Group A : treatment intravenous infusion furosemide ( dose 125-250mg⁄ bid ) plus small volume HSS ( 150mL 1.4-4.6 % NaCl ) , first day admission 3 day discharge ( 8 day treatment ) , water restriction normal sodium diet . Group B : repeat paracentesis ( 4-6L daily ) first day admission 3 day discharge albumin reinfusion rate 5-8g⁄ L remove ascites . The last paracentesis ( 3 day admission 8 day total paracentesis ( 8.1±2.7L ) plus iv albumin infusion ( 8g per liter ascitic fluid remove ) follow method previously describe . Blood sample collection Blood sample subject enrol wil , draw least 30 minute bed rest supine position , within 24h admission 8 day active treatment . Blood sample centrifuge ( 10,000g ) result supernatant immediately frozen -80°C analysis complete . Metabolic immune-inflammatory biochemical evaluation Will evaluate plasma level ANP , BNP , Leptin , visfatin , IL-1β , TNF-a , IL-6 measure use sandwich ELISA ( Human IL-1β , TNF-a , IL-6 6 Diaclone ) . ANP BNP plasma concentration measure duplicate solid phase sandwich immune-radiometric assay human BNP ( IRMA , ANP BNP , Shering ci bio int ) . The minimum detectable concentration diagnostic test : TNF-a : 8pg/mL ; IL-1β : &lt; 1pg/mL ; IL-6 : &lt; 0.81pg/mL ; ANP : 3.1pg/mL ; BNP : 5pg/mL . Leptin visfatin measure ELISA Sandwich ( leptin Mediagnost visfatin Phoenix Pharmaceticals Inc ) ; minimum detectable concentration diagnostic teste : leptin 0.8ng/ml ; visfatin : 1.8ng/ml .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Ascites</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<criteria>Refractory ascites define accord International Ascites Club criterion inability obtain informed consent possible noncirrhotic ascites congestive heart failure ( defined clinical exam echocardiogram ) acute renal failure hepatocellular carcinoma base Barcelona Clinic liver Cancer ( BCLC ) criteria complete portal vein thrombosis , active sepsis incurable cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>cirrhosis</keyword>
	<keyword>ascites</keyword>
	<keyword>immunology</keyword>
	<keyword>inflammation</keyword>
	<keyword>nutrition</keyword>
</DOC>